GET THE APP

..

Journal of Diabetic Complications & Medicine

ISSN: 2475-3211

Open Access

Citations Report

Journal of Diabetic Complications & Medicine : Citations & Metrics Report

Articles published in Journal of Diabetic Complications & Medicine have been cited by esteemed scholars and scientists all around the world.

Journal of Diabetic Complications & Medicine has got h-index 6, which means every article in Journal of Diabetic Complications & Medicine has got 6 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetic Complications & Medicine.

  2022 2021 2020 2019 2018

Year wise published articles

34 30 23 3 6

Year wise citations received

16 18 13 13 7
Journal total citations count 102
Journal impact factor 0.30
Journal 5 years impact factor 0.74
Journal cite score 0.71
Journal h-index 6
Journal h-index since 2018 4
Important citations

Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

Decreased Mortality Associated With the Use of Metformin Compared With Sulfonylurea Monotherapy in Type 2 Diabetes

Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

Hypoglycemia in Type 2 Diabetes Pathophysiology, frequency, and effects of different treatment modalities

The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes A Randomized Trial

The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes

Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic ?-Cell Mass and Function in a Rodent Model of Type 2 Diabetes

Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies

Antidiabetic Effects of Panax ginseng Berry Extract and the Identification of an Effective Component

Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Relevant Topics

arrow_upward arrow_upward